🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Partnered with UI Health, who serves some of the most vulnerable, underserved communities in Illinois, we have gained a deeper understanding of how and why this virus is impacting those communities so drastically. bit.ly/3v9MEDX #AI #COVID19 #digitalbiomarkers

We are thrilled to be working with Nirav Shah and the incredible team at @NorthShoreWeb again on physIQ's NIH-funded DeCODe study. NorthShore will be a key partner in our mission to develop an #AI-based #COVID19 #digitalbiomarker. bit.ly/3wtpxFY

This Wednesday, physIQ is sponsoring the #DigitalBiomarkersSummit where our CMO, Steve Steinhubl, will moderate a panel session w/ industry experts including Jian Yang, Mark Sapp, & Thomas Switzer. We look forward to another great PanAgora Pharma event! bit.ly/35pqUcY

Very insightful conversation with Chris Economos and Pharma's Almanac where they discuss how physIQ is delivering on the promise of #personalizedmedicine by utilizing #AI to improve how drugs are developed and how patients are cared for. bit.ly/3wV1X5g Chris Economos

COVID-19 highlighted the need to improve the way we delivery healthcare. To do this, we must integrate #digitalhealth tools, such #remotepatientmonitoring and #digitalbiomarkers, to improve patient outcomes. bit.ly/3zNFWqC #AI #healthtech #COVID19 #healthcare

As John and Gary come aboard our Leadership team, they will play a critical role in physIQ's expansion strategy and help drive the deployment of the physIQ platform to #healthcare systems and provider groups, #lifesciences and #pharma companies worldwide. bit.ly/3liHUKn

Very excited to attend the #HLTH2021 conference next week. Be sure to stop by and see physIQ at the MATTER Pavilion (1347-17) - hope to see you there!

Welcome to the growing TEAM!

Very excited to partner with the prestigious Purdue University once again to co-develop a viral detection algorithm for smartwatches. The ties between physIQ and Purdue grow stronger by the day! bit.ly/3bgvwoF Purdue Research Foundation #smartwatches #COVID19 #digitalhealth

I had the pleasure to speak with Medium's Authority Magazine about how physIQ's personalized analytics and biosensors are being used to transform #healthcare delivery. bit.ly/3cL9qLE #personalizedmedicine #AI #digitalhealth #digitalmedicine #digitalbiomarkers

Can’t wait for #SCOPE2022 next week in Orlando. If you’re attending and would like to meet with the team and learn how physIQ is transforming #healthcare, please reach out.

Biosensors and digital endpoints are becoming a standard component of #clinicaltrials. That is why physIQ is so excited to announce our collaboration with Science 37 that will deliver on the potential of faster, better clinical trials. bit.ly/32UOHnn

So great to reconnect with a healthcare innovation giant at HIMSS. Thank you Lucien for all you do for our industry. Lucien Engelen Gary Conkright

Join clinical and therapeutic experts from Syneos Health and physIQ as they review the key use cases and measurable benefits generated by #wearable biosensors in #clinicaltrials. Register for the #webinar today: bit.ly/3yNL6Dw

I am pleased to announce that Michael Neeb has joined physIQ as a Special Advisor. He shares our passion for creating world class healthcare solutions derived from a fundamental interest in leveraging medicine & technology to improve the human condition. bit.ly/3QDAWwF

Michael Neeb, a trailblazing leader in #healthcare transformation, has joined physIQ as a Special Advisor. We’re thrilled to have his visionary leadership and knowledge to support our mission to improve health outcomes while reducing cost. bit.ly/3QDAWwF

Very exciting news issued this morning! physIQ is strategically collaborating with InCarda Therapeutics and Syneos Health in a highly innovative study to provide an easier and more convenient treatment for patients with AFib. bit.ly/3R3u1wQ

We are pleased to announce that Jason Luke, MD, FACP, a recognized expert in immuno-oncology, has been appointed to physIQ’s Medical Advisory Board. Dr. Luke will provide expert medical counsel and we could not be more thrilled to welcome him to the TEAM! hubs.ly/Q01p-7jq0

I’m excited to announce that Jason Luke, MD of UPMC has been appointed to physIQ’s Medical Advisory Board. He has extensive immuno-oncology expertise & will provide physIQ with his skilled counsel. We’re thrilled & honored to have him on our growing TEAM. bit.ly/3TcTc1l

“The ability to understand a patient’s physiology at all times in a real-world setting unlocks so much potential. In 15 years, we’ll wonder how we ever approved drugs without continuous data streams” @physIQ's Chris Englerth, PharmaVoice's Year in Preview hubs.ly/Q01vMyyM0